Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.85
Delayed Data
As of Jun 15
 -0.025 / -1.33%
Today’s Change
1.42
Today|||52-Week Range
3.19
-8.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization28.3K27.5K32.9K42.4K
 
 
 
 
 
 
Operating ExpensesGross Income-28.3K-27.5K-32.9K-42.4K
 
 
 
 
 
General Expenses13.2M18.2M16.4M17.3M
 
 
 
 
 
Research And Development7.0M12.1M10.1M10.7M
 
 
 
 
 
Total Operating Expenses13.3M18.3M16.4M17.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.3M-18.3M-16.4M-17.4M
 
 
 
 
 
Extraordinary Credit0.004.0M7.3M0.00
 
 
 
Extraordinary Charge-5.2M0.000.00-7.6M
 
 
 
Interest Expense On Debt0.000.00313.1K0.00
 
 
Other Expenses-206.2K-211.1K0.00-552.6K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.5M-14.4M-9.3M-25.3M
 
 
 
 
 
Net Income-18.5M-14.4M-9.3M-25.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.6M18.2M21.7M27.4M
 
 
 
 
 
Shares To Calculate EPS Diluted17.6M18.2M21.7M27.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.10-$0.80-$0.40-$0.92
 
 
 
 
 
EPS Diluted-$1.10-$0.80-$0.40-$0.92